Skip to content

Proposed Changes to DSHEA Could Impact You — Here’s How

proposed changes to DSHEA

According to the Pew Research Center, many US consumers believe that the current regulatory authority of the Food and Drug Administration (FDA) doesn't adequately protect them. Read further to discover the potential impact of the FDA's proposed changes to the Dietary Supplement Health and Education Act (DSHEA) — and how it could impact your supplement business.

The FDCA Defines a Dietary Supplement and Proposes Changes to the Current Regulatory Landscape

The Federal Food, Drug, and Cosmetic Act (FDCA) defines a dietary supplement as a non-tobacco product intended to supplement the diet. It can contain various ingredients, including vitamins, minerals, herbs, botanicals, and substances used to increase total dietary intake. However, dietary supplements generally cannot contain ingredients used in FDA-approved drugs or investigational new drugs.

Currently, the FDA's regulatory authority over dietary supplements is limited. The FDA can only monitor these products after they have entered the market. The Dietary Supplement Health and Education Act (DSHEA) of 1994 amended the Federal Food, Drug, and Cosmetic Act (FDCA) and provided some regulations for dietary supplements. However, with the rapid growth of the dietary supplement market, the FDA seeks to expand its regulatory authority.

How Proposed Changes to DSHEA Could Impact Your Business

As a business involved in the supplement industry, the proposed changes to DSHEA could have a significant impact on your operations. Let's explore how these changes could affect various types of businesses.

E-commerce Marketplaces

If you operate an online marketplace that facilitates the sale of dietary supplements, it could become crucial for you to ensure that your sellers only offer supplements registered with the FDA.

Internet and Social Media Platforms

If you are a social media platform or an internet company that sells advertisements featuring supplements, the proposed changes to DSHEA could require you to ensure that your advertisers only promote FDA-registered supplements.

Merchants, Merchant Acquirers, and Payment Facilitators

If you are a merchant acquirer or payment service provider working with dietary supplement sellers, the modernization of DSHEA could necessitate vetting the supplements offered by your merchants to ensure FDA registration.

Download Our Comprehensive Guide to Discover How Proposed Changes Could Impact the Regulatory Landscape of Dietary Supplements

The proposed changes to DSHEA could have far-reaching implications for businesses in the supplement industry. As the FDA seeks to modernize its oversight and expand its regulatory authority, it's essential for businesses to stay informed and adapt. For a more comprehensive understanding of the proposed changes to DSHEA and their potential impact on your business, download our guide at the button below.

Smelting words into a specialty since 2020, Thea Le Fevre specializes in B2B SaaS Content Marketing. Take a deep dive into her work for up-to-date industry news surrounding issues in payments risk & compliance, trust & safety, regulatory compliance, and more.

Recent Blog Articles

Why LegitScript Certification Is Your Passport in 2025: A Recap for Healthcare Businesses

In a dynamic regulatory landscape where risk, reputation, and compliance increasingly determine access to financial services, healthcare businesses face a unique challenge. A recent webinar hosted by LegitScript - featuring Rob Bast, chief sales officer at Corepay, and Angela Salter, director of sal...

LegitScript & Special Guest Marketplace Risk Panel Recap: How to Stay Ahead of Global Regulations and Trends: Using Deep Intelligence to Shape Policy and Mitigate Risk

At Marketplace Risk, experts tackled the challenges of content moderation and platform responsibility, focusing on drug-related content, evolving evasion tactics, and the balance between AI and human oversight. Transparency and proactive safety measures took center stage. Listen below to an excerpt...
FDA updates REMS program for common abortion drug mifepristone.

Key Takeaways from LegitScript’s Webinar: Navigating Risks and Regulations in Online Abortion Pill Sales

The online sale of abortion medication is at the center of a rapidly evolving regulatory and risk environment. In LegitScript's June 2025 webinar, Online Abortion Pill Sales: Navigating Regulations and Problematic Activity, experts outlined how recent legal changes are reshaping access to medication...

Merchant Onboarding Essentials: What You Need to Know

Modern merchant onboarding involves much more than collecting documents - it's about building a smart, scalable risk management process that can keep up with changing technology and fraud tactics. Whether you're launching a payments platform or refining your underwriting approach, getting onboarding...